We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BCTXW market cap is 3.29M. The company's latest EPS is USD -0.2621 and P/E is -40.44.
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.5M | -9.85M | -9.27M | -5.88M | -5.22M |
| Net Income | 6M | -11.3M | 1.72M | -1.22M | -5.8M |
| Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.95M | -5.55M | -15.29M | -23.27M | -33.44M |
| Net Income | -4.03M | -428k | -26.84M | -20.3M | -4.79M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.62M | 12.23M | 6.2M | 5.87M | 10.41M |
| Total Liabilities | 16.1M | 20.55M | 12.44M | 8.56M | 6.7M |
| Total Equity | 2.52M | -8.32M | -6.23M | -2.69M | 3.71M |
| Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 522k | 58.04M | 42.58M | 27.16M | 5.87M |
| Total Liabilities | 4.12M | 782k | 32.25M | 30.94M | 8.56M |
| Total Equity | -3.6M | 57.26M | 10.33M | -3.78M | -2.69M |
| Quarter End | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.61M | -15.01M | -20.09M | -24.13M | -6.96M |
| Investing | N/A | N/A | -225k | -682k | -75k |
| Financing | N/A | N/A | N/A | 4.42M | 11.96M |
| Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.27M | -7.75M | -12.48M | -23.75M | -24.13M |
| Investing | N/A | N/A | N/A | N/A | -682k |
| Financing | 1.17M | 64.99M | -3.74M | 3.95M | 4.42M |
| Market Cap | 3.29M |
| Price to Earnings Ratio | -40.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 225.05 |
| Price to Book Ratio | -72.18 |
| Dividend Yield | - |
| Shares Outstanding | 18.28M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.06 (29.84%) |
| Company Name | BriaCell Therapeutics Corporation |
| Address |
suite 300 - 235 west 15th street vancouver, british columbia V7T 2X1 |
| Website | https://www.briacell.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
